OrganiGram Holdings, Inc. (OGRMF)

organigram_logoOrganiGram Holdings, Inc is a Canadian company that develops, produces, and sells condition-specific medicinal marijuana. A licensed producer under Canada’s Marihuana for Medical Purposes Regulations (MMPR), the company currently has 16 strains of medical cannabis in production, and it is developing more.

Condition-specific marijuana means that it targets particular health conditions with a specific formulation using THC and/or CBD, which are the plant’s principal medicinal ingredients. Such treatment can be used for the symptoms or side-effects in patients with HIV/AIDS, cancer, anxiety, muscular dystrophy, spinal cord disease, arthritis, and many others.

OrganiGram’s marijuana strains are grouped into the following: stimulating appetite and controlling nausea (ACN); anxiety and stress disorders (ASD) including PTSD; managing chronic pain (MCP) using marijuana’s analgesic effects; neurological disorders and spasticity (NDS); and dignity, comfort, and quality of life (DCQ) for terminal illnesses and end-of-life care.

OrganiGram markets its products to both patients and doctors interested in medical cannabis. The company sells the products through telephone orders and online stores. In September 2014, it made its first shipment of medical marijuana products to registered and shortlisted customers.

The company was founded as Inform Exploration Corp in 2010. At that time, it was based in Vancouver and engaged in the acquisition and exploration of resource properties. It then became OrganiGram Holdings, Inc only in August 2014, following a reverse takeover.

Today, OrganiGram Holdings, Inc is based in New Brunswick. It is listed in the TSX Venture Exchange under the ticker symbol OGI, and in the US OTC markets under the symbol OGRMF. It has a market value pegged at USD 64.9 M. The company’s top-level executives include Denis Arsenault, Chairman, CEO, and President; Scott Franklin, CFO; and Brett Allan, Director of Investor Relations.

Yahoo! Finance: OGRMF News

Latest Financial News for OGRMF

Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to to view presentations NEW YORK , May 17, 2019 /PRNewswire/ -- Virtual Investor Conferences, ...

Organigram Announces May 21st as Inaugural Date of Trading on the Nasdaq Global Select Market

MONCTON , May 17, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that its common shares will commence trading on the Nasdaq Global Select Market under the symbol "OGI" on Tuesday May 21, 2019 . Organigram's common shares will continue to be listed and trade on the Toronto Venture Exchange (TSXV), also under the symbol "OGI".

Cannastocks2019 Live-Stream Investor Conference & Webinar May 15th

Cannastocks2019 Live-Stream Investor Conference & Webinar May 15th

Organigram Strengthens Leadership Team with Government Relations Expert

MONCTON, NB , May 13, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis is pleased to announce the recent appointment of government relations expert Cameron Bishop as the Company's Vice President, Public Affairs and Stakeholder Relations ( North America ).

Analyzing OrganiGram’s Valuation after Its Earnings

OrganiGram: Analysts' Ratings and Target Price(Continued from Prior Part)ValuationsLately, cannabis stocks have seen a lot of pessimism. Some of the stocks are trading in the “oversold” territory. OrganiGram (OGRMF) has delivered gains since